Selenium Ltd, Austin, Tex, has been awarded a 2-year, $912,943 grant from the National Institute of Dental and Craniofacial Research (NIDCR), one of the National Institutes of Health (NIH), to develop antimicrobial dental devices and water lines.
The company will use the grant to continue its work with SeLECT™ technology, an antimicrobial or antineoplastic coating technology created to reduce the risk of contamination or infection in the orthodontist’s office.
According to the company, SeLECT technology is able to inhibit microbial growth on surfaces through a catalytic reaction that does not leach chemicals or toxins into the surrounding environment.
The NIH has approved $492,972 for the first year and $419,971 for the second year, dependent on Selenium achieving first-year objectives.
For more information about this and other orthodontic companies, visit our Buyer’s Guide.
